Albuquerque-based company lands patent for novel Alzheimer’s technology

The approval is for a "method patent," said Kristina Trujillo, TNeuroPharma's CEO. It's licensed exclusively to TNeuroPharma for the company's method of detecting T-cells in patients to diagnose and treat Alzheimer's.

Blackstone affiliate acquires pair of D.C. hotels from Hersha

2022 Women to Watch: Jenny Sneed, Bridgeworth Wealth Management

Kenosha’s Bear Development advancing two downtown Milwaukee projects

Another Brookfield office building BMO Harris occupies sells

Icahn Enterprises Q4 earnings: 4 things to watch on Thursday

MedMinder switches CEOs for second time in less than two years

Ambitious remake of Raleigh’s Moore Square area features hotel, apartments, restaurants, shops (Renderings)

Form D Friday: $150 million issued for real estate private equity fund

Albuquerque-based company lands patent for novel Alzheimer’s technology

Previous Medical Mutual is leaving downtown Cleveland headquarters

Next Business Coalition on Health hits 10th anniversary with 50 members, 1.5 million covered lives

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

North Loop Green in Minneapolis gears up for early 2024 opening

Here are the leaders and laggards among the state’s biggest private companies

Stellantis site in Bay View could attract ‘hundreds of millions’ in redevelopment

Focus to expand co-working group into suburbs with $10 million buy

Wells Fargo sheds almost 100 jobs in pricey San Francisco

Metro Denver apartment rents are up in 2018, snapping three quarters of declines

MENU

FirstStar Group

More Stories

Shake Shack coming to the Falls